These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8274728)

  • 1. Evolving understanding of the cellular defect in polycythemia vera: implications for its clinical diagnosis and molecular pathophysiology.
    Prchal JT; Prchal JF
    Blood; 1994 Jan; 83(1):1-4. PubMed ID: 8274728
    [No Abstract]   [Full Text] [Related]  

  • 2. Apoptosis and polycythemia vera.
    Fernández-Luna JL
    Curr Opin Hematol; 1999 Mar; 6(2):94-9. PubMed ID: 10088639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective expression of the SHP-1 phosphatase in polycythemia vera.
    Wickrema A; Chen F; Namin F; Yi T; Ahmad S; Uddin S; Chen YH; Feldman L; Stock W; Hoffman R; Platanias LC
    Exp Hematol; 1999 Jul; 27(7):1124-32. PubMed ID: 10390187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium.
    Correa PN; Eskinazi D; Axelrad AA
    Blood; 1994 Jan; 83(1):99-112. PubMed ID: 8274756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera.
    Dai CH; Krantz SB; Sawyer ST
    Blood; 1997 May; 89(10):3574-81. PubMed ID: 9160662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia.
    Sokol L; Prchal JF; D'Andrea A; Rado TA; Prchal JT
    Exp Hematol; 1994 May; 22(5):447-53. PubMed ID: 8174675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.
    Silva M; Richard C; Benito A; Sanz C; Olalla I; Fernández-Luna JL
    N Engl J Med; 1998 Feb; 338(9):564-71. PubMed ID: 9475763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.
    Menier C; Guillard C; Cassinat B; Carosella ED; Rouas-Freiss N
    Leukemia; 2008 Mar; 22(3):578-84. PubMed ID: 18059484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin receptor mutations and Olympic glory.
    Longmore GD
    Nat Genet; 1993 Jun; 4(2):108-10. PubMed ID: 8348144
    [No Abstract]   [Full Text] [Related]  

  • 10. Spontaneous remission of polycythemia vera: clinical and cell culture characteristics.
    Cowan DH; Messner HA; Jamal N; Aye MT; Smiley RK
    Am J Hematol; 1994 May; 46(1):54-6. PubMed ID: 8184876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera.
    Fisher MJ; Prchal JF; Prchal JT; D'Andrea AD
    Blood; 1994 Sep; 84(6):1982-91. PubMed ID: 8081000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing polycythemia vera: a paradigm shift.
    Tefferi A
    Mayo Clin Proc; 1999 Feb; 74(2):159-62. PubMed ID: 10069355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity of polycythemia vera blood burst-forming units-erythroid to interleukin 3.
    Dai CH; Krantz SB; Means RT; Horn ST; Gilbert HS
    Trans Assoc Am Physicians; 1990; 103():249-57. PubMed ID: 2132535
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary polycythemia].
    Mizoguchi H; Takahashi M
    Nihon Rinsho; 1991 Mar; 49(3):599-604. PubMed ID: 1645810
    [No Abstract]   [Full Text] [Related]  

  • 16. Polycythemia vera: myths, mechanisms, and management.
    Spivak JL
    Blood; 2002 Dec; 100(13):4272-90. PubMed ID: 12393615
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-10 inhibits erythropoietin-independent growth of erythroid bursts in patients with polycythemia vera.
    Geissler K; Ohler L; Födinger M; Kabrna E; Kollars M; Skoupy S; Lechner K
    Blood; 1998 Sep; 92(6):1967-72. PubMed ID: 9731054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycythaemia vera.
    de Wolf JT; Vellenga E; Halie MR
    Neth J Med; 1992 Dec; 41(5-6):295-304. PubMed ID: 1494409
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene.
    Divoky V; Liu Z; Ryan TM; Prchal JF; Townes TM; Prchal JT
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):986-91. PubMed ID: 11158582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematopoietic progenitors and signal transduction in polycythaemia vera and primary thrombocythaemia.
    Kralovics R; Prchal JT
    Baillieres Clin Haematol; 1998 Dec; 11(4):803-18. PubMed ID: 10640218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.